| Year |
Citation |
Score |
| 2020 |
Kanel P, Müller MLTM, van der Zee S, Sanchez-Catasus CA, Koeppe RA, Frey KA, Bohnen NI. Topography of Cholinergic Changes in Dementia With Lewy Bodies and Key Neural Network Hubs. The Journal of Neuropsychiatry and Clinical Neurosciences. appineuropsych190701. PMID 32498602 DOI: 10.1176/Appi.Neuropsych.19070165 |
0.331 |
|
| 2020 |
Kramer V, Brooks AF, Haeger A, Kuljs RO, Rafique W, Koeppe RA, Raffel DM, Frey KA, Amaral H, Scott PJH, Riss PJ. Evaluation of [F]N-methyl-lansoprazole as a tau PET imaging agent in first-in-human studies. Acs Chemical Neuroscience. PMID 31898886 DOI: 10.1021/Acschemneuro.9B00639 |
0.312 |
|
| 2019 |
Viglianti BL, Wale DJ, Ma T, Johnson TD, Bohnen NI, Wong KK, Ky C, Frey KA, Townsend DM, Rubello D, Gross MD. Effects of plasma glucose levels on regional cerebral 18F-fluorodeoxyglucose uptake: Implications for dementia evaluation with brain PET imaging. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 112: 108628. PMID 30784923 DOI: 10.1016/J.Biopha.2019.108628 |
0.351 |
|
| 2019 |
Bohnen NI, Kanel P, Zhou Z, Koeppe RA, Frey KA, Dauer WT, Albin RL, Müller MLTM. Cholinergic system changes of falls and freezing of gait in Parkinson disease. Annals of Neurology. PMID 30720884 DOI: 10.1002/Ana.25430 |
0.397 |
|
| 2018 |
Albin RL, Bohnen NI, Muller ML, Dauer WT, Sarter M, Frey KA, Koeppe RA. Regional Vesicular Acetylcholine Transporter Distribution in Human Brain: A [ F]Fluoroethoxybenzovesamicol Positron Emission Tomography Study. The Journal of Comparative Neurology. PMID 30255936 DOI: 10.1002/Cne.24541 |
0.35 |
|
| 2018 |
Nejad-Davarani S, Koeppe RA, Albin RL, Frey KA, Müller MLTM, Bohnen NI. Quantification of brain cholinergic denervation in dementia with Lewy bodies using PET imaging with [F]-FEOBV. Molecular Psychiatry. PMID 30082840 DOI: 10.1038/S41380-018-0130-5 |
0.338 |
|
| 2018 |
Viglianti BL, Wale DJ, Wong KK, Johnson TD, Ky C, Frey KA, Gross MD. Effects of Tumor Burden on Reference Tissue Standardized Uptake for PET Imaging: Modification of PERCIST Criteria. Radiology. 171356. PMID 29558296 DOI: 10.1148/Radiol.2018171356 |
0.319 |
|
| 2017 |
Subramaniam RM, Frey KA, Hunt CH, Mercier GA, Solnes LB, Colletti PM, Lu Y, Savir-Baruch B, Williams HT. ACR-ACNM Practice Parameter for the Performance of Dopamine Transporter (DaT) Single Photon Emission Computed Tomography (SPECT) Imaging for Movement Disorders. Clinical Nuclear Medicine. PMID 28922189 DOI: 10.1097/Rlu.0000000000001815 |
0.37 |
|
| 2017 |
Salloway S, Gamez JE, Singh U, Sadowsky CH, Villena T, Sabbagh MN, Beach TG, Duara R, Fleisher AS, Frey KA, Walker Z, Hunjan A, Escovar YM, Agronin ME, Ross J, et al. Performance of [(18)F]flutemetamol amyloid imaging against the neuritic plaque component of CERAD and the current (2012) NIA-AA recommendations for the neuropathologic diagnosis of Alzheimer's disease. Alzheimer's & Dementia (Amsterdam, Netherlands). 9: 25-34. PMID 28795133 DOI: 10.1016/J.Dadm.2017.06.001 |
0.32 |
|
| 2017 |
Kong FM, Ten Haken RK, Schipper M, Frey KA, Hayman J, Gross M, Ramnath N, Hassan KA, Matuszak M, Ritter T, Bi N, Wang W, Orringer M, Cease KB, Lawrence TS, et al. Effect of Midtreatment PET/CT-Adapted Radiation Therapy With Concurrent Chemotherapy in Patients With Locally Advanced Non-Small-Cell Lung Cancer: A Phase 2 Clinical Trial. Jama Oncology. PMID 28570742 DOI: 10.1001/Jamaoncol.2017.0982 |
0.303 |
|
| 2017 |
Viglianti BL, Wong KK, Wimer SM, Paraeswaran A, Nan B, Ky C, Townsend DM, Rubello D, Frey KA, Gross MD. Effect of hyperglycemia on brain and liver (18)F-FDG standardized uptake value (FDG SUV) measured by quantitative positron emission tomography (PET) imaging. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 88: 1038-1045. PMID 28192877 DOI: 10.1016/J.Biopha.2017.01.166 |
0.329 |
|
| 2017 |
Frey KA. Molecular Imaging of Extrapyramidal Movement Disorders. Seminars in Nuclear Medicine. 47: 18-30. PMID 27987553 DOI: 10.1053/J.Semnuclmed.2016.09.007 |
0.305 |
|
| 2016 |
Scott PJ, Shao X, Desmond TJ, Hockley BG, Sherman P, Quesada CA, Frey KA, Koeppe RA, Kilbourn MR, Bohnen NI. Investigation of Proposed Activity of Clarithromycin at GABAA Receptors Using [(11)C]Flumazenil PET. Acs Medicinal Chemistry Letters. 7: 746-50. PMID 27563397 DOI: 10.1021/Acsmedchemlett.5B00435 |
0.387 |
|
| 2016 |
Wong KK, Raffel DM, Bohnen NI, Altinok G, Gilman S, Frey KA. 2-Year Natural Decline of Cardiac Sympathetic Innervation in Idiopathic Parkinson Disease Studied with 11C-Hydroxyephedrine (HED) PET. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 27539837 DOI: 10.2967/Jnumed.116.176891 |
0.319 |
|
| 2016 |
Haugen J, Müller ML, Kotagal V, Albin RL, Koeppe RA, Scott PJ, Frey KA, Bohnen NI. Prevalence of impaired odor identification in Parkinson disease with imaging evidence of nigrostriatal denervation. Journal of Neural Transmission (Vienna, Austria : 1996). PMID 26911386 DOI: 10.1007/S00702-016-1524-7 |
0.316 |
|
| 2015 |
Frey KA, Lodge MA, Meltzer CC, Peller PJ, Wong TZ, Hess CP, Petrella JR, Sair HI, Subramaniam RM. ACR-ASNR Practice Parameter for Brain PET/CT Imaging Dementia. Clinical Nuclear Medicine. PMID 26646994 DOI: 10.1097/Rlu.0000000000001037 |
0.334 |
|
| 2015 |
Albin RL, Fisher-Hubbard A, Shanmugasundaram K, Koeppe RA, Burke JF, Camelo-Piragua S, Lieberman AP, Giordani B, Frey KA. Post-Mortem evaluation of amyloid-dopamine terminal positron emission tomography dementia classifications. Annals of Neurology. PMID 26183692 DOI: 10.1002/Ana.24481 |
0.335 |
|
| 2015 |
Petrou M, Dwamena BA, Foerster BR, MacEachern MP, Bohnen NI, Müller ML, Albin RL, Frey KA. Amyloid deposition in Parkinson's disease and cognitive impairment: A systematic review. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 928-35. PMID 25879534 DOI: 10.1002/Mds.26191 |
0.332 |
|
| 2015 |
Frey KA, Petrou M. Imaging Amyloidopathy in Parkinson Disease and Parkinsonian Dementia Syndromes. Clinical and Translational Imaging. 3: 57-64. PMID 25745616 DOI: 10.1007/S40336-015-0104-4 |
0.336 |
|
| 2015 |
Frey KA. Amyloid imaging in dementia: contribution or confusion? Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 56: 331-2. PMID 25655624 DOI: 10.2967/Jnumed.114.151571 |
0.301 |
|
| 2015 |
Curtis C, Gamez JE, Singh U, Sadowsky CH, Villena T, Sabbagh MN, Beach TG, Duara R, Fleisher AS, Frey KA, Walker Z, Hunjan A, Holmes C, Escovar YM, Vera CX, et al. Phase 3 trial of flutemetamol labeled with radioactive fluorine 18 imaging and neuritic plaque density. Jama Neurology. 72: 287-94. PMID 25622185 DOI: 10.1001/Jamaneurol.2014.4144 |
0.305 |
|
| 2015 |
Thomas AC, Brown RK, Begum R, Srinivasan A, Bohnen NI, Frey KA. Autoimmune limbic encephalitis detected on FDG brain scan performed for the evaluation of dementia. Clinical Nuclear Medicine. 40: 358-9. PMID 25608163 DOI: 10.1097/Rlu.0000000000000702 |
0.339 |
|
| 2015 |
Bohnen NI, Albin RL, Müller ML, Petrou M, Kotagal V, Koeppe RA, Scott PJ, Frey KA. Frequency of cholinergic and caudate nucleus dopaminergic deficits across the predemented cognitive spectrum of Parkinson disease and evidence of interaction effects. Jama Neurology. 72: 194-200. PMID 25506674 DOI: 10.1001/Jamaneurol.2014.2757 |
0.302 |
|
| 2015 |
Müller ML, Bohnen NI, Kotagal V, Scott PJ, Koeppe RA, Frey KA, Albin RL. Clinical markers for identifying cholinergic deficits in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 269-73. PMID 25393613 DOI: 10.1002/Mds.26061 |
0.324 |
|
| 2015 |
Frey K, Perani D. Amyloid PET imaging: a challenge for research in clinical neuroimaging Clinical and Translational Imaging. 3: 3-5. DOI: 10.1007/S40336-015-0105-3 |
0.335 |
|
| 2014 |
Bohnen NI, Frey KA, Studenski S, Kotagal V, Koeppe RA, Constantine GM, Scott PJ, Albin RL, Müller ML. Extra-nigral pathological conditions are common in Parkinson's disease with freezing of gait: an in vivo positron emission tomography study. Movement Disorders : Official Journal of the Movement Disorder Society. 29: 1118-24. PMID 24909584 DOI: 10.1002/Mds.25929 |
0.358 |
|
| 2014 |
Fawaz MV, Brooks AF, Rodnick ME, Carpenter GM, Shao X, Desmond TJ, Sherman P, Quesada CA, Hockley BG, Kilbourn MR, Albin RL, Frey KA, Scott PJ. High affinity radiopharmaceuticals based upon lansoprazole for PET imaging of aggregated tau in Alzheimer's disease and progressive supranuclear palsy: synthesis, preclinical evaluation, and lead selection. Acs Chemical Neuroscience. 5: 718-30. PMID 24896980 DOI: 10.1021/Cn500103U |
0.363 |
|
| 2014 |
Brown RK, Bohnen NI, Wong KK, Minoshima S, Frey KA. Brain PET in suspected dementia: patterns of altered FDG metabolism. Radiographics : a Review Publication of the Radiological Society of North America, Inc. 34: 684-701. PMID 24819789 DOI: 10.1148/Rg.343135065 |
0.335 |
|
| 2014 |
Petrou M, Frey KA, Kilbourn MR, Scott PJ, Raffel DM, Bohnen NI, Müller ML, Albin RL, Koeppe RA. In vivo imaging of human cholinergic nerve terminals with (-)-5-(18)F-fluoroethoxybenzovesamicol: biodistribution, dosimetry, and tracer kinetic analyses. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 55: 396-404. PMID 24481024 DOI: 10.2967/Jnumed.113.124792 |
0.333 |
|
| 2013 |
Bohnen NI, Frey KA, Studenski S, Kotagal V, Koeppe RA, Scott PJ, Albin RL, Müller ML. Gait speed in Parkinson disease correlates with cholinergic degeneration. Neurology. 81: 1611-6. PMID 24078735 DOI: 10.1212/Wnl.0B013E3182A9F558 |
0.311 |
|
| 2013 |
Müller ML, Albin RL, Kotagal V, Koeppe RA, Scott PJ, Frey KA, Bohnen NI. Thalamic cholinergic innervation and postural sensory integration function in Parkinson's disease. Brain : a Journal of Neurology. 136: 3282-9. PMID 24056537 DOI: 10.1093/Brain/Awt247 |
0.345 |
|
| 2013 |
Albin RL, Burke JF, Koeppe RA, Giordani B, Gilman S, Frey KA. Assessing mild cognitive impairment with amyloid and dopamine terminal molecular imaging. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 54: 887-93. PMID 23572495 DOI: 10.2967/Jnumed.112.112599 |
0.36 |
|
| 2013 |
Kotagal V, Albin RL, Müller ML, Koeppe RA, Frey KA, Bohnen NI. Gender differences in cholinergic and dopaminergic deficits in Parkinson disease. Journal of Neural Transmission (Vienna, Austria : 1996). 120: 1421-4. PMID 23532360 DOI: 10.1007/S00702-013-1013-1 |
0.324 |
|
| 2013 |
Müller ML, Frey KA, Petrou M, Kotagal V, Koeppe RA, Albin RL, Bohnen NI. β-Amyloid and postural instability and gait difficulty in Parkinson's disease at risk for dementia. Movement Disorders : Official Journal of the Movement Disorder Society. 28: 296-301. PMID 23239424 DOI: 10.1002/Mds.25213 |
0.336 |
|
| 2012 |
Shao X, Carpenter GM, Desmond TJ, Sherman P, Quesada CA, Fawaz M, Brooks AF, Kilbourn MR, Albin RL, Frey KA, Scott PJ. Evaluation of [(11)C]N-Methyl Lansoprazole as a Radiopharmaceutical for PET Imaging of Tau Neurofibrillary Tangles. Acs Medicinal Chemistry Letters. 3: 936-41. PMID 24900410 DOI: 10.1021/Ml300216T |
0.347 |
|
| 2012 |
Kotagal V, Bohnen NI, Müller ML, Koeppe RA, Frey KA, Albin RL. Cerebral amyloid deposition and serotoninergic innervation in Parkinson disease. Archives of Neurology. 69: 1628-31. PMID 22964894 DOI: 10.1001/Archneurol.2012.764 |
0.35 |
|
| 2012 |
Petrou M, Bohnen NI, Müller ML, Koeppe RA, Albin RL, Frey KA. Aβ-amyloid deposition in patients with Parkinson disease at risk for development of dementia. Neurology. 79: 1161-7. PMID 22933741 DOI: 10.1212/Wnl.0B013E3182698D4A |
0.352 |
|
| 2012 |
Lelieveld IM, Müller ML, Bohnen NI, Koeppe RA, Chervin RD, Frey KA, Albin RL. The role of serotonin in sleep disordered breathing associated with Parkinson disease: a correlative [11C]DASB PET imaging study. Plos One. 7: e40166. PMID 22792235 DOI: 10.1371/Journal.Pone.0040166 |
0.327 |
|
| 2012 |
Bohnen NI, Müller ML, Kotagal V, Koeppe RA, Kilbourn MR, Gilman S, Albin RL, Frey KA. Heterogeneity of cholinergic denervation in Parkinson's disease without dementia. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 32: 1609-17. PMID 22569194 DOI: 10.1038/Jcbfm.2012.60 |
0.346 |
|
| 2012 |
Kotagal V, Albin RL, Müller ML, Koeppe RA, Chervin RD, Frey KA, Bohnen NI. Symptoms of rapid eye movement sleep behavior disorder are associated with cholinergic denervation in Parkinson disease. Annals of Neurology. 71: 560-8. PMID 22522445 DOI: 10.1002/Ana.22691 |
0.347 |
|
| 2011 |
Bohnen NI, Müller ML, Zarzhevsky N, Koeppe RA, Bogan CW, Kilbourn MR, Frey KA, Albin RL. Leucoaraiosis, nigrostriatal denervation and motor symptoms in Parkinson's disease. Brain : a Journal of Neurology. 134: 2358-65. PMID 21653540 DOI: 10.1093/Brain/Awr139 |
0.322 |
|
| 2011 |
Bohnen NI, Koeppe RA, Minoshima S, Giordani B, Albin RL, Frey KA, Kuhl DE. Cerebral glucose metabolic features of Parkinson disease and incident dementia: longitudinal study. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 52: 848-55. PMID 21571793 DOI: 10.2967/Jnumed.111.089946 |
0.338 |
|
| 2011 |
Burke JF, Albin RL, Koeppe RA, Giordani B, Kilbourn MR, Gilman S, Frey KA. Assessment of mild dementia with amyloid and dopamine terminal positron emission tomography. Brain : a Journal of Neurology. 134: 1647-57. PMID 21555336 DOI: 10.1093/Brain/Awr089 |
0.34 |
|
| 2010 |
Hansen N, Brown RK, Khan A, Frey KA, Orringer M. False positive diagnosis of metastatic esophageal carcinoma on positron emission tomography: a case report of cholecystitis simulating a hepatic lesion. Clinical Nuclear Medicine. 35: 409-12. PMID 20479586 DOI: 10.1097/Rlu.0B013E3181Db4Cd2 |
0.325 |
|
| 2010 |
Bohnen NI, Müller ML, Kotagal V, Koeppe RA, Kilbourn MA, Albin RL, Frey KA. Olfactory dysfunction, central cholinergic integrity and cognitive impairment in Parkinson's disease. Brain : a Journal of Neurology. 133: 1747-54. PMID 20413575 DOI: 10.1093/Brain/Awq079 |
0.351 |
|
| 2010 |
Albin RL, Koeppe RA, Burke JF, Giordani B, Kilbourn MR, Gilman S, Frey KA. Comparing fludeoxyglucose F18-PET assessment of regional cerebral glucose metabolism and [11C]dihydrotetrabenazine-PET in evaluation of early dementia and mild cognitive impairment. Archives of Neurology. 67: 440-6. PMID 20385910 DOI: 10.1001/Archneurol.2010.34 |
0.343 |
|
| 2010 |
Kilbourn MR, Butch ER, Desmond T, Sherman P, Harris PE, Frey KA. In vivo [11C]dihydrotetrabenazine binding in rat striatum: sensitivity to dopamine concentrations Nuclear Medicine and Biology. 37: 3-8. PMID 20122661 DOI: 10.1016/J.Nucmedbio.2009.08.013 |
0.369 |
|
| 2010 |
Mody RJ, Bui C, Hutchinson RJ, Yanik GA, Castle VP, Frey KA, Shulkin BL. FDG PET imaging of childhood sarcomas. Pediatric Blood & Cancer. 54: 222-7. PMID 19890901 DOI: 10.1002/Pbc.22307 |
0.3 |
|
| 2009 |
Bohnen NI, Müller ML, Koeppe RA, Studenski SA, Kilbourn MA, Frey KA, Albin RL. History of falls in Parkinson disease is associated with reduced cholinergic activity. Neurology. 73: 1670-6. PMID 19917989 DOI: 10.1212/Wnl.0B013E3181C1Ded6 |
0.332 |
|
| 2009 |
Fahim C, Yoon U, Sandor P, Frey K, Evans AC. Thinning of the motor-cingulate-insular cortices in siblings concordant for Tourette syndrome. Brain Topography. 22: 176-84. PMID 19779823 DOI: 10.1007/S10548-009-0105-6 |
0.301 |
|
| 2009 |
Kilbourn MR, Hockley B, Lee L, Sherman P, Quesada C, Frey KA, Koeppe RA. Positron emission tomography imaging of (2R,3R)-5-[18F]fluoroethoxybenzovesamicol in rat and monkey brain: a radioligand for the vesicular acetylcholine transporter Nuclear Medicine and Biology. 36: 489-493. PMID 19520289 DOI: 10.1016/J.Nucmedbio.2009.02.007 |
0.346 |
|
| 2009 |
Wong KK, Zarzhevsky N, Cahill JM, Frey KA, Avram AM. Hybrid SPECT-CT and PET-CT imaging of differentiated thyroid carcinoma. The British Journal of Radiology. 82: 860-76. PMID 19433487 DOI: 10.1259/Bjr/25645894 |
0.311 |
|
| 2009 |
Albin RL, Koeppe RA, Wernette K, Zhuang W, Nichols T, Kilbourn MR, Frey KA. Striatal [11C]dihydrotetrabenazine and [11C]methylphenidate binding in Tourette syndrome. Neurology. 72: 1390-6. PMID 19380698 DOI: 10.1212/Wnl.0B013E3181A187Dd |
0.357 |
|
| 2008 |
Koeppe RA, Gilman S, Junck L, Wernette K, Frey KA. Differentiating Alzheimer's disease from dementia with Lewy bodies and Parkinson's disease with (+)-[11C]dihydrotetrabenazine positron emission tomography. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 4: S67-76. PMID 18632004 DOI: 10.1016/J.Jalz.2007.11.016 |
0.359 |
|
| 2008 |
Li X, Jung YW, Snyder SE, Blair J, Sherman PS, Desmond T, Frey KA, Kilbourn MR. 5-tert-Butyl-2-(4′-[18F]fluoropropynylphenyl)-1,3-dithiane oxides: potential new GABAA receptor radioligands Nuclear Medicine and Biology. 35: 549-559. PMID 18589299 DOI: 10.1016/J.Nucmedbio.2007.08.003 |
0.358 |
|
| 2008 |
Albin RL, Koeppe RA, Bohnen NI, Wernette K, Kilbourn MA, Frey KA. Spared caudal brainstem SERT binding in early Parkinson's disease. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 28: 441-4. PMID 18073772 DOI: 10.1038/Sj.Jcbfm.9600599 |
0.357 |
|
| 2008 |
Kilbourn MR, Butch E, Desmond T, Sherman P, Frey K. Dopamine depletion increases in vivo [11C]DTBZ binding in awake rat brain Neuroimage. 41: T54. DOI: 10.1016/J.Neuroimage.2008.04.228 |
0.351 |
|
| 2007 |
Mody RJ, Bui C, Hutchinson RJ, Frey KA, Shulkin BL. Comparison of (18)F Flurodeoxyglucose PET with Ga-67 scintigraphy and conventional imaging modalities in pediatric lymphoma. Leukemia & Lymphoma. 48: 699-707. PMID 17454627 DOI: 10.1080/10428190601179783 |
0.319 |
|
| 2007 |
Bohnen NI, Frey KA. Imaging of cholinergic and monoaminergic neurochemical changes in neurodegenerative disorders. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 9: 243-57. PMID 17318670 DOI: 10.1007/S11307-007-0083-6 |
0.37 |
|
| 2006 |
Johanson CE, Frey KA, Lundahl LH, Keenan P, Lockhart N, Roll J, Galloway GP, Koeppe RA, Kilbourn MR, Robbins T, Schuster CR. Cognitive function and nigrostriatal markers in abstinent methamphetamine abusers. Psychopharmacology. 185: 327-38. PMID 16518646 DOI: 10.1007/S00213-006-0330-6 |
0.34 |
|
| 2006 |
Bohnen NI, Albin RL, Koeppe RA, Wernette KA, Kilbourn MR, Minoshima S, Frey KA. Positron emission tomography of monoaminergic vesicular binding in aging and Parkinson disease. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 26: 1198-212. PMID 16421508 DOI: 10.1038/Sj.Jcbfm.9600276 |
0.366 |
|
| 2006 |
Kuhl DE, Koeppe RA, Snyder SE, Minoshima S, Frey KA, Kilbourn MR. In vivo butyrylcholinesterase activity is not increased in Alzheimer's disease synapses. Annals of Neurology. 59: 13-20. PMID 16278840 DOI: 10.1002/Ana.20672 |
0.32 |
|
| 2005 |
Clinton SM, Ibrahim HM, Frey KA, Davis KL, Haroutunian V, Meador-Woodruff JH. Dopaminergic abnormalities in select thalamic nuclei in schizophrenia: involvement of the intracellular signal integrating proteins calcyon and spinophilin. The American Journal of Psychiatry. 162: 1859-71. PMID 16199832 DOI: 10.1176/Appi.Ajp.162.10.1859 |
0.312 |
|
| 2005 |
Koeppe RA, Gilman S, Junck L, Heumann M, Wernette K, Frey KA. Differentiation of Lewy body dementia from Parkinson's disease with [C-11]DTBZ PET Journal of Cerebral Blood Flow & Metabolism. 25: S393-S393. DOI: 10.1038/Sj.Jcbfm.9591524.0393 |
0.337 |
|
| 2004 |
Kilbourn MR, Kemmerer ES, Desmond TJ, Sherman PS, Frey KA. Differential effects of scopolamine on in vivo binding of dopamine transporter and vesicular monoamine transporter radioligands in rat brain Experimental Neurology. 188: 387-390. PMID 15246838 DOI: 10.1016/J.Expneurol.2004.05.001 |
0.738 |
|
| 2004 |
Lucignani G, Panzacchi A, Bosio L, Moresco RM, Ravasi L, Coppa I, Chiumello G, Frey K, Koeppe R, Fazio F. GABAA receptor abnormalities in Prader-Willi syndrome assessed with positron emission tomography and [11C]flumazenil Neuroimage. 22: 22-28. PMID 15109994 DOI: 10.1016/J.Neuroimage.2003.10.050 |
0.31 |
|
| 2004 |
Minoshima S, Frey KA, Cross DJ, Kuhl DE. Neurochemical imaging of dementias. Seminars in Nuclear Medicine. 34: 70-82. PMID 14735460 DOI: 10.1053/J.Semnuclmed.2003.09.008 |
0.301 |
|
| 2004 |
Montgomery EB, Pan T, Le W, Jankovic J, Ahlskog JE, Wooten GF, Albin RL, Frey KA. Slowing Parkinson's disease progression: Recent dopamine agonist trials [3] (multiple letters) Neurology. 62: 343-345. DOI: 10.1212/Wnl.62.2.343 |
0.308 |
|
| 2003 |
Bohnen NI, Frey KA. The role of positron emission tomography imaging in movement disorders. Neuroimaging Clinics of North America. 13: 791-803. PMID 15024962 DOI: 10.1016/S1052-5149(03)00096-0 |
0.393 |
|
| 2003 |
Brooks DJ, Frey KA, Marek KL, Oakes D, Paty D, Prentice R, Shults CW, Stoessl AJ. Assessment of neuroimaging techniques as biomarkers of the progression of Parkinson's disease Experimental Neurology. 184. PMID 14597329 DOI: 10.1016/J.Expneurol.2003.08.008 |
0.377 |
|
| 2003 |
Kemmerer ES, Desmond TJ, Albin RL, Kilbourn MR, Frey KA. Treatment effects on nigrostriatal projection integrity in partial 6-OHDA lesions: comparison of L-DOPA and pramipexole. Experimental Neurology. 183: 81-6. PMID 12957491 DOI: 10.1016/S0014-4886(03)00096-7 |
0.723 |
|
| 2003 |
Albin RL, Koeppe RA, Bohnen NI, Nichols TE, Meyer P, Wernette K, Minoshima S, Kilbourn MR, Frey KA. Increased ventral striatal monoaminergic innervation in Tourette syndrome. Neurology. 61: 310-5. PMID 12913189 DOI: 10.1212/01.Wnl.0000076181.39162.Fc |
0.381 |
|
| 2003 |
Albin RL, Cross D, Cornblath WT, Wald JA, Wernette K, Frey KA, Minoshima S. Diminished striatal [123I]iodobenzovesamicol binding in idiopathic cervical dystonia. Annals of Neurology. 53: 528-32. PMID 12666122 DOI: 10.1002/Ana.10527 |
0.37 |
|
| 2003 |
Albin RL, Frey KA. Initial agonist treatment of Parkinson disease: a critique. Neurology. 60: 390-4. PMID 12580185 DOI: 10.1212/01.Wnl.0000052681.28286.52 |
0.302 |
|
| 2002 |
Minoshima S, Foster NL, Petrie EC, Albin RL, Frey KA, Kuhl DE. Neuroimaging in dementia with Lewy bodies: metabolism, neurochemistry, and morphology. Journal of Geriatric Psychiatry and Neurology. 15: 200-9. PMID 12489916 DOI: 10.1177/089198870201500405 |
0.332 |
|
| 2002 |
Suzuki M, Desmond TJ, Albin RL, Frey KA. Striatal monoaminergic terminals in Lewy body and Alzheimer's dementias. Annals of Neurology. 51: 767-71. PMID 12112084 DOI: 10.1002/Ana.10186 |
0.337 |
|
| 2002 |
Suzuki M, Desmond TJ, Albin RL, Frey KA. Cholinergic vesicular transporters in progressive supranuclear palsy. Neurology. 58: 1013-8. PMID 11940684 DOI: 10.1212/Wnl.58.7.1013 |
0.358 |
|
| 2001 |
Minoshima S, Foster NL, Sima AA, Frey KA, Albin RL, Kuhl DE. Alzheimer's disease versus dementia with Lewy bodies: cerebral metabolic distinction with autopsy confirmation. Annals of Neurology. 50: 358-65. PMID 11558792 DOI: 10.1002/Ana.1133 |
0.3 |
|
| 2001 |
Suzuki M, Desmond TJ, Albin RL, Frey KA. Vesicular neurotransmitter transporters in Huntington's disease: initial observations and comparison with traditional synaptic markers. Synapse (New York, N.Y.). 41: 329-36. PMID 11494403 DOI: 10.1002/Syn.1089 |
0.367 |
|
| 2001 |
Zubieta JK, Koeppe RA, Frey KA, Kilbourn MR, Mangner TJ, Foster NL, Kuhl DE. Assessment of muscarinic receptor concentrations in aging and Alzheimer disease with [11C]NMPB and PET. Synapse (New York, N.Y.). 39: 275-87. PMID 11169777 DOI: 10.1002/1098-2396(20010315)39:4<275::Aid-Syn1010>3.0.Co;2-3 |
0.353 |
|
| 2001 |
Zubieta JK, Taylor SF, Huguelet P, Koeppe RA, Kilbourn MR, Frey KA. Vesicular monoamine transporter concentrations in bipolar disorder type I, schizophrenia, and healthy subjects. Biological Psychiatry. 49: 110-6. PMID 11164757 DOI: 10.1016/S0006-3223(00)00981-1 |
0.35 |
|
| 2000 |
Taylor SF, Koeppe RA, Tandon R, Zubieta JK, Frey KA. In vivo measurement of the vesicular monoamine transporter in schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 23: 667-75. PMID 11063922 DOI: 10.1016/S0893-133X(00)00165-2 |
0.366 |
|
| 2000 |
Zubieta JK, Huguelet P, Ohl LE, Koeppe RA, Kilbourn MR, Carr JM, Giordani BJ, Frey KA. High vesicular monoamine transporter binding in asymptomatic bipolar I disorder: sex differences and cognitive correlates. The American Journal of Psychiatry. 157: 1619-28. PMID 11007716 DOI: 10.1176/Appi.Ajp.157.10.1619 |
0.304 |
|
| 2000 |
Kuhl DE, Minoshima S, Frey KA, Foster NL, Kilbourn MR, Koeppe RA. Limited donepezil inhibition of acetylcholinesterase measured with positron emission tomography in living Alzheimer cerebral cortex. Annals of Neurology. 48: 391-5. PMID 10976649 DOI: 10.1002/1531-8249(200009)48:3<391::Aid-Ana17>3.0.Co;2-H |
0.308 |
|
| 2000 |
Bohnen NI, Koeppe RA, Meyer P, Ficaro E, Wernette K, Kilbourn MR, Kuhl DE, Frey KA, Albin RL. Decreased striatal monoaminergic terminals in Huntington disease. Neurology. 54: 1753-9. PMID 10802780 DOI: 10.1212/Wnl.54.9.1753 |
0.387 |
|
| 1999 |
Koeppe RA, Frey KA, Kuhl DE, Kilbourn MR. Assessment of extrastriatal vesicular monoamine transporter binding site density using stereoisomers of [11C]dihydrotetrabenazine. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 19: 1376-84. PMID 10598942 DOI: 10.1097/00004647-199912000-00011 |
0.38 |
|
| 1999 |
Koeppe RA, Frey KA, Snyder SE, Meyer P, Kilbourn MR, Kuhl DE. Kinetic modeling of N-[11C]methylpiperidin-4-yl propionate: alternatives for analysis of an irreversible positron emission tomography trace for measurement of acetylcholinesterase activity in human brain. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 19: 1150-63. PMID 10532640 DOI: 10.1097/00004647-199910000-00012 |
0.302 |
|
| 1999 |
Meyer P, Bohnen NI, Minoshima S, Koeppe RA, Wernette K, Kilbourn MR, Kuhl DE, Frey KA, Albin RL. Striatal presynaptic monoaminergic vesicles are not increased in Tourette's syndrome. Neurology. 53: 371-4. PMID 10430428 DOI: 10.1212/Wnl.53.2.371 |
0.395 |
|
| 1999 |
Bohnen NI, Albin RL, Frey KA, Fink JK. (+)-alpha-[11C]Dihydrotetrabenazine PET imaging in familial paroxysmal dystonic choreoathetosis. Neurology. 52: 1067-9. PMID 10102431 DOI: 10.1212/Wnl.52.5.1067 |
0.369 |
|
| 1999 |
Kuhl DE, Koeppe RA, Minoshima S, Snyder SE, Ficaro EP, Foster NL, Frey KA, Kilbourn MR. In vivo mapping of cerebral acetylcholinesterase activity in aging and Alzheimer's disease. Neurology. 52: 691-9. PMID 10078712 DOI: 10.1212/Wnl.52.4.691 |
0.329 |
|
| 1999 |
Bohnen NI, Minoshima S, Giordani B, Frey KA, Kuhl DE. Motor correlates of occipital glucose hypometabolism in Parkinson's disease without dementia. Neurology. 52: 541-6. PMID 10025784 DOI: 10.1212/Wnl.52.3.541 |
0.31 |
|
| 1999 |
Pennell PB, Burdette DE, Ross DA, Henry TR, Albin RL, Sackellares JC, Frey KA. Muscarinic receptor loss and preservation of presynaptic cholinergic terminals in hippocampal sclerosis. Epilepsia. 40: 38-46. PMID 9924900 DOI: 10.1111/J.1528-1157.1999.Tb01986.X |
0.313 |
|
| 1999 |
Snyder SE, Sherman PS, Desmond TJ, Frey KA, Kilbourn MR. (-)-6',7'-[11C]dihydroroten-12α-ol ((-)-[11C]DHROL) for in vivo measurement of mitochondrial complex I Journal of Labelled Compounds and Radiopharmaceuticals. 42: 641-652. DOI: 10.1002/(Sici)1099-1344(199907)42:7<641::Aid-Jlcr226>3.0.Co;2-Y |
0.334 |
|
| 1998 |
Mulholland GK, Wieland DM, Kilbourn MR, Frey KA, Sherman PS, Carey JE, Kuhl DE. [18F]fluoroethoxy-benzovesamicol, a PET radiotracer for the vesicular acetylcholine transporter and cholinergic synapses. Synapse (New York, N.Y.). 30: 263-74. PMID 9776130 DOI: 10.1002/(Sici)1098-2396(199811)30:3<263::Aid-Syn4>3.0.Co;2-9 |
0.363 |
|
| 1998 |
Kearney JA, Becker JB, Frey KA, Albin RL. The role of nigrostriatal dopamine in metabotropic glutamate agonist-induced rotation. Neuroscience. 87: 881-91. PMID 9759976 DOI: 10.1016/S0306-4522(98)00193-6 |
0.314 |
|
| 1998 |
Zubieta JK, Koeppe RA, Mulholland GK, Kuhl DE, Frey KA. Quantification of muscarinic cholinergic receptors with [11C]NMPB and positron emission tomography: method development and differentiation of tracer delivery from receptor binding. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 18: 619-31. PMID 9626186 DOI: 10.1097/00004647-199806000-00004 |
0.369 |
|
| 1998 |
Frey K, Kilbourn M, Robinson T. Reduced striatal vesicular monoamine transporters after neurotoxic but not after behaviorally-sensitizing doses of methamphetamine. European Journal of Pharmacology. 334: 273-9. PMID 9369358 DOI: 10.1016/S0014-2999(97)01152-7 |
0.337 |
|
| 1998 |
Frey KA, Wieland DM, Kilbourn MR. Imaging of monoaminergic and cholinergic vesicular transporters in the brain Advances in Pharmacology (San Diego, Calif.). 42: 269-272. PMID 9327896 DOI: 10.1016/S1054-3589(08)60745-0 |
0.37 |
|
| 1997 |
Koeppe RA, Frey KA, Kume A, Albin R, Kilbourn MR, Kuhl DE. Equilibrium versus compartmental analysis for assessment of the vesicular monoamine transporter using (+)-alpha-[11C]dihydrotetrabenazine (DTBZ) and positron emission tomography. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 17: 919-31. PMID 9307605 DOI: 10.1097/00004647-199709000-00001 |
0.326 |
|
| 1997 |
Macdonald GA, Frey KA, Agranoff BW, Minoshima S, Koeppe RA, Kuhl DE, Shulkin BL, Lucey MR. Cerebral benzodiazepine receptor binding in vivo in patients with recurrent hepatic encephalopathy. Hepatology (Baltimore, Md.). 26: 277-82. PMID 9252134 DOI: 10.1002/Hep.510260204 |
0.395 |
|
| 1997 |
Minoshima S, Giordani B, Berent S, Frey KA, Foster NL, Kuhl DE. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease. Annals of Neurology. 42: 85-94. PMID 9225689 DOI: 10.1002/Ana.410420114 |
0.323 |
|
| 1997 |
Kilbourn MR, Charalambous A, Frey KA, Sherman P, Higgins DS, Greenamyre JT. Intrastriatal neurotoxin injections reduce in vitro and in vivo binding of radiolabeled rotenoids to mitochondrial complex I. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 17: 265-72. PMID 9119899 DOI: 10.1097/00004647-199703000-00003 |
0.327 |
|
| 1997 |
Kilbourn M, Frey K. Striatal concentrations of vesicular monoamine transporters are identical in MPTP-sensitive (C57BL/6) and -insensitive (CD-1) mouse strains. European Journal of Pharmacology. 307: 227-32. PMID 8832225 DOI: 10.1016/0014-2999(96)00252-X |
0.311 |
|
| 1996 |
Gilman S, Frey KA, Koeppe RA, Junck L, Little R, Vander Borght TM, Lohman M, Martorello S, Lee LC, Jewett DM, Kilbourn MR. Decreased striatal monoaminergic terminals in olivopontocerebellar atrophy and multiple system atrophy demonstrated with positron emission tomography. Annals of Neurology. 40: 885-92. PMID 9007093 DOI: 10.1002/Ana.410400610 |
0.358 |
|
| 1996 |
Frey KA, Koeppe RA, Kilbourn MR, Vander Borght TM, Albin RL, Gilman S, Kuhl DE. Presynaptic monoaminergic vesicles in Parkinson's disease and normal aging. Annals of Neurology. 40: 873-84. PMID 9007092 DOI: 10.1002/Ana.410400609 |
0.418 |
|
| 1996 |
Buck A, Mulholland GK, Papadopoulos SM, Koeppe RA, Frey KA. Kinetic evaluation of positron-emitting muscarinic receptor ligands employing direct intracarotid injection Journal of Cerebral Blood Flow and Metabolism. 16: 1280-1287. PMID 8898702 DOI: 10.1097/00004647-199611000-00024 |
0.308 |
|
| 1996 |
Kilbourn MR, Frey KA, Vander Borght T, Sherman PS. Effects of dopaminergic drug treatments on in vivo radioligand binding to brain vesicular monoamine transporters Nuclear Medicine and Biology. 23: 467-471. PMID 8832701 DOI: 10.1016/0969-8051(96)00023-6 |
0.341 |
|
| 1996 |
Kuhl DE, Minoshima S, Fessler JA, Frey KA, Foster NL, Ficaro EP, Wieland DM, Koeppe RA. In vivo mapping of cholinergic terminals in normal aging, Alzheimer's disease, and Parkinson's disease. Annals of Neurology. 40: 399-410. PMID 8797529 DOI: 10.1002/Ana.410400309 |
0.375 |
|
| 1996 |
Jung YW, Frey KA, Mulholland GK, del Rosario R, Sherman PS, Raffel DM, Van Dort ME, Kuhl DE, Gildersleeve DL, Wieland DM. Vesamicol receptor mapping of brain cholinergic neurons with radioiodine-labeled positional isomers of benzovesamicol. Journal of Medicinal Chemistry. 39: 3331-42. PMID 8765517 DOI: 10.1021/Jm9507486 |
0.36 |
|
| 1996 |
Albin RL, Minoshima S, D'Amato CJ, Frey KA, Kuhl DA, Sima AA. Fluoro-deoxyglucose positron emission tomography in diffuse Lewy body disease. Neurology. 47: 462-6. PMID 8757021 DOI: 10.1212/Wnl.47.2.462 |
0.322 |
|
| 1996 |
Frey KA, Minoshima S, Koeppe RA, Kilbourn MR, Berger KL, Kuhl DE. Stereotaxic summation analysis of human cerebral benzodiazepine binding maps. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 16: 409-17. PMID 8621745 DOI: 10.1097/00004647-199605000-00007 |
0.339 |
|
| 1996 |
Lee KS, Frey KA, Koeppe RA, Buck A, Mulholland GK, Kuhl DE. In vivo quantification of cerebral muscarinic receptors in normal human aging using positron emission tomography and [11C]tropanyl benzilate. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 16: 303-10. PMID 8594063 DOI: 10.1097/00004647-199603000-00016 |
0.369 |
|
| 1996 |
Lee LC, Borght TV, Sherman PS, Frey KA, Kilbourn MR. In vitro and in vivo studies of benzisoquinoline ligands for the brain synaptic vesicle monoamine transporter Journal of Medicinal Chemistry. 39: 191-196. PMID 8568807 DOI: 10.1021/Jm950117B |
0.339 |
|
| 1995 |
Vander Borght T, Kilbourn M, Desmond T, Kuhl D, Frey K. The vesicular monoamine transporter is not regulated by dopaminergic drug treatments. European Journal of Pharmacology. 294: 577-83. PMID 8750721 DOI: 10.1016/0014-2999(95)00594-3 |
0.354 |
|
| 1995 |
Vander Borght TM, Sima AA, Kilbourn MR, Desmond TJ, Kuhl DE, Frey KA. [3H]methoxytetrabenazine: a high specific activity ligand for estimating monoaminergic neuronal integrity. Neuroscience. 68: 955-62. PMID 8577387 DOI: 10.1016/0306-4522(95)00167-H |
0.34 |
|
| 1995 |
Meyer M, Koeppe RA, Frey KA, Foster NL, Kuhl DE. Positron emission tomography measures of benzodiazepine binding in Alzheimer's disease. Archives of Neurology. 52: 314-7. PMID 7872887 DOI: 10.1001/Archneur.1995.00540270110027 |
0.354 |
|
| 1995 |
Burdette DE, Sakurai SY, Henry TR, Ross DA, Pennell PB, Frey KA, Sackellares JC, Albin RL. Temporal lobe central benzodiazepine binding in unilateral mesial temporal lobe epilepsy. Neurology. 45: 934-41. PMID 7746410 DOI: 10.1212/Wnl.45.5.934 |
0.308 |
|
| 1995 |
Mulholland GK, Kilbourn MR, Sherman P, Carey JE, Frey KA, Koeppe RA, Kuhl DE. Synthesis, in vivo biodistribution and dosimetry of [11C]N-methylpiperidyl benzilate ([11C]NMPB), a muscarinic acetylcholine receptor antagonist. Nuclear Medicine and Biology. 22: 13-7. PMID 7735163 DOI: 10.1016/0969-8051(94)00082-U |
0.328 |
|
| 1995 |
Minoshima S, Frey KA, Foster NL, Kuhl DE. Preserved pontine glucose metabolism in Alzheimer disease: a reference region for functional brain image (PET) analysis. Journal of Computer Assisted Tomography. 19: 541-7. PMID 7622680 DOI: 10.1097/00004728-199507000-00006 |
0.337 |
|
| 1995 |
Kilbourn M, Lee L, Vander Borght T, Jewett D, Frey K. Binding of alpha-dihydrotetrabenazine to the vesicular monoamine transporter is stereospecific. European Journal of Pharmacology. 278: 249-52. PMID 7589162 DOI: 10.1016/0014-2999(95)00162-E |
0.306 |
|
| 1994 |
Koeppe RA, Frey KA, Mulholland GK, Kilbourn MR, Buck A, Lee KS, Kuhl DE. [11C]tropanyl benzilate-binding to muscarinic cholinergic receptors: methodology and kinetic modeling alternatives. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 14: 85-99. PMID 8263062 DOI: 10.1038/Jcbfm.1994.13 |
0.326 |
|
| 1994 |
Albin RL, Howland MM, Higgins DS, Frey KA. Autoradiographic quantification of muscarinic cholinergic synaptic markers in bat, shrew, and rat brain. Neurochemical Research. 19: 581-9. PMID 8065514 DOI: 10.1007/Bf00971334 |
0.313 |
|
| 1993 |
Kilbourn MR, DaSilva JN, Frey KA, Koeppe RA, Kuhl DE. In vivo imaging of vesicular monoamine transporters in human brain using [11C]tetrabenazine and positron emission tomography. Journal of Neurochemistry. 60: 2315-8. PMID 8492135 DOI: 10.1111/J.1471-4159.1993.Tb03521.X |
0.387 |
|
| 1993 |
Henry TR, Frey KA, Sackellares JC, Gilman S, Koeppe RA, Brunberg JA, Ross DA, Berent S, Young AB, Kuhl DE. In vivo cerebral metabolism and central benzodiazepine-receptor binding in temporal lobe epilepsy. Neurology. 43: 1998-2006. PMID 8413957 DOI: 10.1212/Wnl.43.10.1998 |
0.311 |
|
| 1993 |
Meyer MA, Frey KA, Schwaiger M. Discordance between F-18 fluorodeoxyglucose uptake and contrast enhancement in a brain abscess. Clinical Nuclear Medicine. 18: 682-4. PMID 8403702 DOI: 10.1097/00003072-199308000-00013 |
0.338 |
|
| 1993 |
Holthoff VA, Koeppe RA, Frey KA, Penney JB, Markel DS, Kuhl DE, Young AB. Positron emission tomography measures of benzodiazepine receptors in Huntington's disease. Annals of Neurology. 34: 76-81. PMID 8390806 DOI: 10.1002/Ana.410340114 |
0.343 |
|
| 1992 |
Frey KA, Koeppe RA, Mulholland GK, Jewett D, Hichwa R, Ehrenkaufer RL, Carey JE, Wieland DM, Kuhl DE, Agranoff BW. In vivo muscarinic cholinergic receptor imaging in human brain with [11C]scopolamine and positron emission tomography. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 12: 147-54. PMID 1727135 DOI: 10.1038/Jcbfm.1992.18 |
0.362 |
|
| 1991 |
Holthoff VA, Koeppe RA, Frey KA, Paradise AH, Kuhl DE. Differentiation of radioligand delivery and binding in the brain: validation of a two-compartment model for [11C]flumazenil. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 11: 745-52. PMID 1874806 DOI: 10.1038/Jcbfm.1991.131 |
0.367 |
|
| 1991 |
Frey KA, Ciliax B, Agranoff BW. Quantitative in vivo receptor binding. IV: Detection of muscarinic receptor down-regulation by equilibrium and by tracer kinetic methods. Neurochemical Research. 16: 1017-23. PMID 1784328 DOI: 10.1007/Bf00965845 |
0.333 |
|
| 1991 |
Frey KA, Holthoff VA, Koeppe RA, Jewett DM, Kilbourn MR, Kuhl DE. Parametric in vivo imaging of benzodiazepine receptor distribution in human brain. Annals of Neurology. 30: 663-72. PMID 1662476 DOI: 10.1002/Ana.410300506 |
0.364 |
|
| 1991 |
Koeppe RA, Holthoff VA, Frey KA, Kilbourn MR, Kuhl DE. Compartmental analysis of [11C]flumazenil kinetics for the estimation of ligand transport rate and receptor distribution using positron emission tomography. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 11: 735-44. PMID 1651944 DOI: 10.1038/Jcbfm.1991.130 |
0.33 |
|
| 1985 |
Olds JL, Frey KA, Ehrenkaufer RL, Agranoff BW. A sequential double-label autoradiographic method that quantifies altered rates of regional glucose metabolism. Brain Research. 361: 217-24. PMID 4084794 DOI: 10.1016/0006-8993(85)91292-2 |
0.324 |
|
| 1985 |
Frey KA, Hichwa RD, Ehrenkaufer RL, Agranoff BW. Quantitative in vivo receptor binding III: Tracer kinetic modeling of muscarinic cholinergic receptor binding. Proceedings of the National Academy of Sciences of the United States of America. 82: 6711-5. PMID 3876561 DOI: 10.1073/Pnas.82.19.6711 |
0.338 |
|
| 1985 |
Frey K, Ehrenkaufer R, Agranoff B. Quantitative in vivo receptor binding. II. Autoradiographic imaging of muscarinic cholinergic receptors The Journal of Neuroscience. 5: 2407-2414. DOI: 10.1523/Jneurosci.05-09-02407.1985 |
0.352 |
|
| 1985 |
Frey K, Ehrenkaufer R, Beaucage S, Agranoff B. Quantitative in vivo receptor binding. I. Theory and application to the muscarinic cholinergic receptor The Journal of Neuroscience. 5: 421-428. DOI: 10.1523/Jneurosci.05-02-00421.1985 |
0.336 |
|
| 1983 |
Pan HS, Frey KA, Young AB, Penney JB. Changes in [3H]muscimol binding in substantia nigra, entopeduncular nucleus, globus pallidus, and thalamus after striatal lesions as demonstrated by quantitative receptor autoradiography. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 3: 1189-98. PMID 6304260 DOI: 10.1523/Jneurosci.03-06-01189.1983 |
0.342 |
|
| 1981 |
Penney JB, Pan HS, Young AB, Frey KA, Dauth GW. Quantitative autoradiography of [3H]muscimol binding in rat brain. Science (New York, N.Y.). 214: 1036-8. PMID 6272394 DOI: 10.1126/Science.6272394 |
0.339 |
|
| Show low-probability matches. |